An Observational Study Exploring the Esthetic Outcomes of Breast Reduction Surgery and /or Mastopexy

December 22, 2015 updated by: Orbix Medical Ltd.
The purpose of the study is to collect data regarding the aesthetic outcomes of patients who had breast reduction surgery and /or mastopexy in terms such as scaring, patient satisfaction, breast ptosis assessment including taking photographs and filling questionnaires.

Study Overview

Status

Terminated

Conditions

Detailed Description

This is a prospective observational study, single center cohort to explore the aesthetic outcomes of patients who had breast reduction and / or mastopxy surgery. The surgical intervention will be determined by the clinician with no correlation to this study.

The study will focus on the aesthetic aspects of the clinical outcome resultant from the breast surgery in par course of 5 years. Scar tissue assessment and patient's reported data (satisfaction and well-being) will be collected.

Suitable patients will be assessed for study eligibility at a screening visit and, if eligible, will be scheduled for breast surgery according to the patient and surgeon discretion.

At each follow up visit, patients will undergo clinical general examination, breast and ptosis endearments, scar appearance , aesthetic evaluation. Patients will fill satisfaction questionnaires

Study Type

Observational

Enrollment (Actual)

5

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tel Aviv, Israel
        • The Plastic Surgery Department The Tel Aviv Sourasky Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 55 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Female Patients, 30 years of age or older referred for elective breast reduction surgery and /or mastopxy

Description

Inclusion Criteria:

  1. Female patient older than 30 years of age.
  2. Patients willing to participate as evidenced by signing the written informed consent.
  3. Patient that was found by her physician illegible for breast reduction surgery and /or mastopxy

Exclusion Criteria:

1. Active psychiatric illness, cognitive or sensory impairment. 2. Physical impairment that may prevent filling out a paper and pencil survey or responding to interview questions

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
observation
no specific treatment. Long term observation the results of any breast lifting or reduction surgeries

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measuring the aesthetic outcomes of pre /post- surgical breast ptosis
Time Frame: during 5 years post- surgically

Breast measurements consists on:

  • Breast cup size
  • Distortions or skin retractions
  • Symmetry between the two breasts
  • Ptosis grade evaluated on the basis of an I-IV scale
  • Methods to measure breast shape and symmetry
  • Skin texture (soft or hard)
  • Skin consistency
  • Nipple location on the breast mound scored on a scale of 1 - 5
  • Areola diameter (mm)
  • The shape of the breast scored on a scale of 1 - 5
  • Scar Appearance evaluation -VAS score
  • Patient satisfaction questionnaires
during 5 years post- surgically

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Arik Zaretski, MD, TASMC

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2013

Primary Completion (ACTUAL)

November 1, 2015

Study Completion (ACTUAL)

November 1, 2015

Study Registration Dates

First Submitted

December 10, 2013

First Submitted That Met QC Criteria

December 15, 2013

First Posted (ESTIMATE)

December 20, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

December 23, 2015

Last Update Submitted That Met QC Criteria

December 22, 2015

Last Verified

October 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • CLI-02

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Macromastia

Subscribe